Impact of Ca2+ signaling on B cell function

Trends in Immunology

Volumn 32, Issue 12, 2011, Pages 589-594

  Baba, Yoshihiro ^a,b   Kurosaki, Tomohiro ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; CD19 ANTIGEN; CD22 ANTIGEN; CD40 ANTIGEN; FC RECEPTOR IIB; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE SHP 1; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR NFAT; CALCIUM;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; B LYMPHOCYTE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; COMMON VARIABLE IMMUNODEFICIENCY; CYTOPLASM; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; X LINKED AGAMMAGLOBULINEMIA; ANIMAL; EXTRACELLULAR SPACE; IMMUNOLOGY; METABOLISM;

ANIMALS; B-LYMPHOCYTES; CALCIUM; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; EXTRACELLULAR SPACE; HUMANS;

EID: 81355127403     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.09.004     Document Type: Review

References (71)

1. Berridge M.J., et al. Calcium: calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
2. Feske S. Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 2007, 7:690-702.
3. Lewis R.S. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 2001, 19:497-521.
4. Vig M., Kinet J.-P. Calcium signaling in immune cells. Nat. Immunol. 2009, 10:21-27.
5. Kurosaki T., et al. B cell signaling and fate decision. Annu. Rev. Immunol. 2009, 28:21-25.
6. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat. Rev. Immunol. 2010, 4:236-247.
7. Mauri C., Ehrenstein M.R. The 'short' history of regulatory B cells. Trends Immunol. 2008, 29:34-40.
8. Bouaziz J.-D., et al. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 2008, 224:201-214.
9. Kurosaki T. Regulation of B-cell signal transduction by adaptor proteins. Nat. Rev. Immunol. 2002, 2:354-363.
10. Parekh A.B., Putney J.W. Store-operated calcium channels. Physiol. Rev. 2005, 85:757-810.
11. Putney J.W. A model for receptor-regulated calcium entry. Cell Calcium 1986, 7:1-12.
12. Roos J., et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 2005, 169:435-445.
13. Liou J., et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 2005, 15:1235-1241.
14. Feske S., et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441:179-185.
15. Vig M. CRACM1 Is a plasma membrane protein essential for store-operated Ca2+ entry. Science 2006, 312:1220-1223.
16. Baba Y., Kurosaki T. Physiological function and molecular basis of STIM1-mediated calcium entry in immune cells. Immunol. Rev. 2009, 231:174-188.
17. Baba Y., et al. Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16704-16709.
18. Hogan P.G., et al. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 2010, 28:491-533.
19. Wang Y., et al. Calcium signaling by STIM and Orai: intimate coupling details revealed. Sci. Signal. 2010, 3. pe42-pe42.
20. Carter R.H., Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256:105-107.
21. Fujimoto M., et al. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation. J. Biol. Chem. 2001, 276:44820-44827.
22. Tedder T.F., et al. CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses. Biochem. Soc. Trans. 2002, 30:807-811.
23. van Zelm M.C., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 2006, 354:1901-1912.
24. Tuveson D.A., et al. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993, 260:986-989.
25. D'Ambrosio D., et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 1995, 268:293-297.
26. Ono M., et al. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 1996, 383:263-266.
27. Nitschke L., et al. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 1997, 7:133-143.
28. Liu Q., et al. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 1998, 188:1333-1342.
29. Chen J., et al. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat. Immunol. 2004, 5:651-657.
30. Miller A.T., et al. Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation. Nat. Immunol. 2007, 8:514-521.
31. Stork B., et al. Grb2 and the non-T cell activation linker NTAL constitute a Ca(2+)-regulating signal circuit in B lymphocytes. Immunity 2004, 21:681-691.
32. Jang I.K., et al. Growth-factor receptor-bound protein-2 (Grb2) signaling in B cells controls lymphoid follicle organization and germinal center reaction. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7926-7931.
33. Ackermann J.A., et al. Grb2 regulates B-cell maturation, B-cell memory responses and inhibits B-cell Ca2+ signalling. EMBO J. 2011, 30:1621-1633.
34. Neumann K., et al. The B-lymphoid Grb2 interaction code. Immunol. Rev. 2009, 232:135-149.
35. Waisman A., et al. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J. Exp. Med. 2007, 204:747-758.
36. Horikawa K., et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J. Exp. Med. 2007, 204:759-769.
37. Engels N., et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat. Immunol. 2009, 10:1018-1025.
38. Conley M.E., et al. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol. Rev. 1994, 138:5-21.
39. Minegishi Y., et al. An essential role for BLNK in human B cell development. Science 1999, 286:1954-1957.
40. Kanegane H., et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun. 2007, 8:663-670.
41. Shultz L.D., et al. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 1997, 15:302-307.
42. O'Keefe T.L., et al. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 1999, 189:1307-1313.
43. Nitschke L. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr. Opin. Immunol. 2005, 17:290-297.
44. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285.
45. Enyedy E.J., et al. Defective FcγRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus. Clin. Immunol. 2001, 101:130-135.
46. Yu P., et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 2005, 22:451-465.
47. Picard C., et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N. Engl. J. Med. 2009, 360:1971-1980.
48. Feske S., et al. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin. Immunol. 2010, 135:169-182.
49. Matsumoto M., et al. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011, 34:703-714.
50. Baba Y., et al. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 2008, 9:81-88.
51. Oh-hora M., et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat. Immunol. 2008, 9:432-443.
52. Mizoguchi A., Bhan A.K. A case for regulatory B cells. J. Immunol. 2006, 176:705-710.
53. Timmerman L.A., et al. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 1996, 383:837-840.
54. Shibasaki F., et al. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996, 382:370-373.
55. Dolmetsch R.E., et al. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997, 386:855-858.
56. Healy J.I., et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997, 6:419-428.
57. Fillatreau S., et al. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
58. Neves P., et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010, 33:777-790.
59. Goodnow C.C., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676-682.
60. Meffre E., et al. Antibody regulation of B cell development. Nat. Immunol. 2000, 1:379-385.
61. Burnet F.M., Fenner F. The Production of Antibodies 1949, Macmillan. 2nd edn.
62. Limnander A., et al. STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat. Immunol. 2011, 12:425-433.
63. Schroppel B., Heeger P.S. Gazing into a crystal ball to predict kidney transplant outcome. J. Clin. Invest. 2010, 120:1803-1806.
64. Blair P.A., et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
65. Fillatreau S., et al. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 2008, 8:391-397.
66. Harris N., Gause W.C. To B or not to B: B cells and the Th2-type immune response to helminths. Trends Immunol. 2011, 32:80-88.
67. Mizoguchi A., et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16:219-230.
68. Watanabe R., et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am. J. Pathol. 2007, 171:560-570.
69. Evans J.G., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 2007, 178:7868-7878.
70. Yanaba K., et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
71. Matsushita T., et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008, 118:3420-3430.